Primaa

The power of AI for Pathologists

Paris, France · Founded 2018 · $7.8M raised

Headquarters
Paris
Employees
11–50
Founded
2018
Business Model
B2B
Total Funding
$7.8M
Last Round
$7.8M Series BOct 2025
Rounds
3

About

Primaa is a MedTech company developing AI-based software for automated cancer diagnosis in histopathology. Founded in 2018 in Paris by pathologist Marie Sockeel, the company flagship product Cleo uses deep learning and computer vision to assist pathologists in identifying cancer biomarkers on whole slide images, with CE-marked solutions for breast cancer and — as of 2026 — the world first CE IVDR-certified AI tool for dermatopathology. With a team of 22 including PhDs, MDs, and data scientists, Primaa partners with leading digital pathology platforms including PathAI, Proscia, and Gestalt, and has expanded into the U.S. market.

Summary

Primaa is an Artificial Intelligence company based in Paris, France, founded in 2018. It has raised $7.8M in total across 3 rounds, most recently a $7.8M Series B round in Oct 2025. Investors include Elaia, MH Innov and Swen CP.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BOct 2025
$7.8M

Sign up to see all 3 rounds

Seed through Series B — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Primaa on Indexed.vc
<a href="https://indexed.vc/companies/primaa"><img src="https://indexed.vc/api/badge/company/primaa" alt="Primaa on Indexed.vc" width="260" height="76" /></a>